Report Content
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Market scope & definitions
1.3 Base estimates and calculations
1.3.1 North America
1.3.2 Europe
1.3.3 Asia Pacific
1.3.4 Latin America
1.3.5 MEA
1.4 Forecast calculations
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Point of care molecular diagnostics industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Technology trends
2.1.3 Application trends
2.1.4 End-use trends
2.1.5 Regional trends
Chapter 3 Point of Care Molecular Diagnostics Industry Insights
3.1 Industry landscape
3.2 Pricing analysis 2018 – 2032
3.2.1 Pricing analysis, by region
3.2.1.1 North America
3.2.1.2 Europe
3.2.1.3 Asia Pacific
3.2.1.4 Latin America
3.2.1.5 Middle East & Africa
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing incidence of infectious diseases
3.3.1.2 Increasing R&D funding to reduce time required for molecular diagnostic tests
3.3.1.3 Growing awareness about pre-disease diagnostics to control occurrence of diseases
3.3.1.4 Technological advancements in DNA sequencing and analysis
3.3.2 Industry pitfalls & challenges
3.3.2.1 Long product development time
3.3.2.2 Complex regulatory process
3.4 Growth potential analysis
3.4.1 By technology
3.4.2 By application
3.4.3 By end-use
3.5 COVID- 19 impact analysis
3.6 Technology landscape
3.7 Regulatory landscape
3.7.1 U.S.
3.7.2 Europe
3.8 Porter's analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape
4.1 Introduction
4.1.1 Abbott Laboratories
4.1.2 Bio-Rad Laboratories, Inc
4.1.3 BioMérieux SA
4.2 Competitive dashboard, 2021
4.3 Company matrix analysis, 2021
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategic outlook matrix
Chapter 5 Point of Care Molecular Diagnostics Market, By Technology
5.1 Key technology trends
5.2 Polymerase Chain Reaction (PCR)
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 In situ hybridization
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4 Sequecing
5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.5 Isothermal amplification
5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.6 Others
5.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 6 Point of Care Molecular Diagnostics Market, By Application
6.1 Key application trends
6.2 Infectious diseases
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.2.2 Flu
6.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.2.3 Respiratory syncytial virus (RSV)
6.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.2.4 Tuberculosis (TB)
6.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.2.5 HIV
6.2.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.2.6 Gonorrhea
6.2.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.2.7 Chlamydia
6.2.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.2.8 Hepatitis C
6.2.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.2.9 Hepatitis B
6.2.9.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.2.10 COVID-19
6.2.10.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.2.11 Others
6.2.11.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Oncology
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 Hematology
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.5 Others
6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 Point of Care Molecular Diagnostics Market, By End-use
7.1 Key end-use trends
7.2 Hospitals
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Clinics
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.4 Diagnostic centers
7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.5 Others
7.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 8 Point of Care Molecular Diagnostics Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Russia
8.4 Asia Pacific
8.4.1 China
8.4.2 India
8.4.3 Japan
8.4.4 South Korea
8.4.5 Malaysia
8.4.6 Thailand
8.4.7 Vietnam
8.4.8 Philippines
8.4.9 Australia
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.6 Middle East & Africa
8.6.1 South Africa
8.6.2 Nigeria
8.6.3 Egypt
8.6.4 Morocco
8.6.5 Saudi Arabia
8.6.6 UAE
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 BioMérieux SA
9.3 Bio-Rad Laboratories, Inc
9.4 Danaher Corporation
9.5 Sysmex Corporation
9.6 Abaxis Inc
9.7 Mesa Biotech (Thermo Fisher Scientific)
9.8 Roche Diagnostics
9.9 OraSure Technologies, Inc
9.10 VIRCELL S.L
